Will Price Controls Limit Drug Development? The Debate Heats Up.

Legislative proposals for curbing outlays on prescription drugs have moved to center stage, as Congress looks hard for ways to pay for costly initiatives to repair the nation’s infrastructure, offset global warming and expand health care programs. These developments have focused attention on a recent report from the bipartisan Congressional Budget Office (CBO) analyzing how drug pricing policies could reduce the number of new therapies coming to market.

Read the source article at Applied Clinical Trials Online
2021-09-02 22:00:00